Mercer Global Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Mercer Global Advisors's ASND Position: Q3 2026 in Review
Mercer Global Advisors increased its Ascendis Pharma (ASND) stake by 34% in Q3 2026, buying an estimated $114K and bringing the position to 1,785 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #2690.
Mercer Global Advisors first reported a position in ASND in Q2 2025 and has held it in 6 quarters since. The position peaked at $540K in Q2 2025. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- Mercer Global Advisors held 1,785 shares of Ascendis Pharma worth $407K as of Q3 2026.
- Mercer Global Advisors bought 449 Ascendis Pharma shares in Q3 2026, an estimated $114K.
- Ascendis Pharma made up ﹤0.01% of Mercer Global Advisors's portfolio in Q3 2026, its #2690 holding.
- Mercer Global Advisors first reported a position in Ascendis Pharma in Q2 2025 and has held it in 6 quarters since.
- Mercer Global Advisors's Ascendis Pharma position peaked at $540K in Q2 2025.
- 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on Mercer Global Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.